StocksMedium•9 November 2026•
1 min read
Quanterix Reports Mixed Q3 Results with Revenue Beat Amid Wider Losses
Key Facts
1Quanterix reported a Q3 GAAP loss per share of $0.46, missing analyst estimates by $0.04.
2Q3 revenue reached $35 million, beating expectations by $1.15 million despite a 13% year-on-year decline.
3Nine-month revenue grew by 10%, supported by strategic shifts and regulatory approvals in China.
Quanterix reported a Q3 2026 GAAP loss per share of $0.46, missing analyst estimates by $0.04 according to TradingView. Revenue for the quarter reached $35 million, exceeding expectations by $1.15 million despite representing a 13% decline compared to the same period last year.
The year-on-year revenue decline was driven by weakness in instruments and laboratory services, though nine-month revenue grew by 10% following strategic shifts and regulatory approvals in China. QTRX closed at $2.9 on November 6, 2026, as the company looks toward a positive 2027 outlook supported by diagnostic reimbursement milestones and international growth.